Arie Mayer insider trades
Open-market stock purchases and sales by Arie Mayer, Director at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Jan 8, 2020.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +86%.
Companies traded
- ORMP Oramed Pharmaceuticals Inc: 2 buys, 1 sale, last Dec 31, 2025